Research Article
Have Changes in Systemic Treatment Improved Survival in Patients with Breast Cancer Metastatic to the Brain?
Table 2
Survival results for the two groups.
| | Contemporary group, | Historical group, | (log-rank test) |
| | Median survival | 5.0 mo. | 3.6 mo. | | | 1-year survival | 31% | 19% | <.1 | | Median survival RPA class II | 9.0 mo. | 3.4 mo. | | | 1-year survival RPA class II | 42% | 22% | <.05 | | Median survival RPA class III | 2.4 mo. | 3.1 mo. | | | 1-year survival RPA class III | 18% | 8% | >.1 | |
|
|
